Navigation Links
Research yields two 'firsts' regarding protein crucial to human cardiac function
Date:8/31/2012

TALLAHASSEE, Fla. -- Florida State University researchers led by physics doctoral student Campion Loong have achieved significant benchmarks in a study of the human cardiac protein alpha-tropomyosin, which is an essential, molecular-level component that controls the heart's contraction on every beat.

Using an imaging method called atomic force microscopy, Loong achieved two "firsts": the first direct imaging of individual alpha-tropomyosin molecules, which are very small roughly 40 nanometers long and the first demonstrated examples of a measure of the human cardiac protein's flexibility. From there, he established a baseline of how flexible a normal version of the protein is supposed to be in a healthy human heart.

"This basic research is important to broadening our understanding of how the human heart functions normally at the molecular level," Loong said. "The flexibility of alpha-tropomyosin dictates how effectively or properly the heart muscle will contract on each beat and has implications for keeping the heart free of cardiovascular disease.

"Before this study, we did not know how flexible this protein was," Loong said. "Using these results, now we can conduct subsequent studies to compare disease-related mutants of this protein to see how much they deviate from normal versions."

Loong served as the lead author of the paper "Persistence Length of Human Cardiac a-Tropomyosin Measured by Single Molecule Direct Probe Microscopy," which was published in the journal PLoS ONE. He conducted the research with physics Professor Huan-Xiang Zhou and biological science Professor P. Bryant Chase, both of Florida State.

When an electrical signal is generated in the heart to make it contract, calcium is released inside each heart muscle cell. The calcium then binds to a protein called troponin, and that triggers the "flexing movement" of alpha-tropomyosin, which allows another protein called myosin the motor protein to interact with the troponin/tropomyosin actin filaments. This series of events is what generates the heart's contraction that pumps blood. A subsequent removal of calcium inside each heart cell is what relaxes the heart, which allows the heart to fill with blood to be pumped on the next beat.

"Alpha-tropomyosin is a key element that makes the calcium signal either turn the heart on, making it contract, or turn it off, making it relax," Chase said. "There is an optimal range of flexibility of alpha-tropomyosin for the normal heart to function properly. The molecule can be too stiff or it can be too flexible, either of which could lead to cardiovascular disease. What we ultimately think is that evolution has tuned the mechanical properties of these proteins for optimal function in the heart."


'/>"/>

Contact: P. Bryant Chase
chase@bio.fsu.edu
850-644-0392
Florida State University
Source:Eurekalert  

Related biology news :

1. BUSM researchers find potential key to halt progression, reverse damage from emphysema
2. Researchers launch new Rust-Tracker to monitor deadly wheat fungus in 27 nations
3. Science research led in Gulf of Mexico by Penn State biologist to be honored with US award
4. University of Tennessee Space Institute researchers make clinical trials a virtual reality
5. £30 million boost for biomedical engineering research
6. New equipment is breath of fresh air for childrens lung researchers
7. Mount Sinai researchers solve mystery surrounding the death of two sisters nearly 50 years ago
8. Biomass characterization technology research highlighted in Industrial Biotechnology journal
9. Stanford researchers discover the anternet
10. By detecting smallest virus, researchers open possibilities for early disease detection
11. African research identifies strong candidate for possible single-dose malaria cure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research yields two 'firsts' regarding protein crucial to human cardiac function
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
(Date:11/22/2016)... 22, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... and Life Sciences Awards as "Most Outstanding in ... unprecedented year of recognition and growth for MedNet, which ... years. iMedNet ™ , MedNet,s ...
(Date:11/19/2016)... Securus Technologies, a leading provider of civil and criminal ... monitoring, announced today that it has offered a challenge ... technology judge determine who has the largest and best ... platform, and the best customer service. "ICSolutions ... we do – which clearly is not the case ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... 5, 2016  Renova™ Therapeutics, a biotechnology company ... and other chronic diseases, announced that Catherine ... Chief Financial Officer (CFO), effective today. ... of experience in financial management for a variety ... companies. Most recently, Ms. Bovenizer was the Vice ...
(Date:12/5/2016)... YORK , December 5, 2016 ... player worldwide, with almost $108 billion of revenue and ... $170 billion were spent on global biopharmaceuticals, and this ... This morning, Stock-Callers.com has lined up these four equities ... ), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), ...
(Date:12/2/2016)... ... December 02, 2016 , ... In anticipation ... and lumbar disc production, company President, Jake Lubinski will be traveling to Switzerland ... AxioMed disc in Bern, Lucerne, and Zurich to discuss the benefits of a ...
(Date:12/2/2016)... -- Research and Markets has announced the addition ... Companies" to their offering. ... , , ... industries is anticipated. Nanotechnology will be applied at all stages ... diagnostic applications in clinical trials. Many of the assays based ...
Breaking Biology Technology: